Sharon H. Hrynkow, Ph.D. is Founder and Managing Partner of Global Health Consulting LLC. In this role, she assists clients in the biotechnology and scientific/technology space more broadly on corporate strategy, growth opportunities, including those related to non-dilutive funding, and she provides scientific advice, including as Chair of corporate S & T committees. She serves additionally as an Independent Corporate Director. Dr. Hrynkow, a neuroscientist by training, served for 7 years as Chief Scientific Officer and Senior Vice President for Medical Affairs at Cyclo Therapeutics, Inc., a clinical stage pharmaceutical company working to develop drugs for the treatment of Niemann-Pick Disease type C and Alzheimer’s Disease. She and the CEO raised more than $30 million to transform the company. Prior to this, Dr. Hrynkow devoted 20 years to public service, including in leadership roles in global health at the National Institutes of Health (Fogarty International Center and National Institute of Environmental Health Sciences) and the Department of State. She also served as the inaugural President of the non-profit organization, Global Virus Network. Dr. Hrynkow has received numerous honors and recognitions for her service to society. As a member of the Senior Executive Service, she received the President’s Rank Award for Meritorious Senior Executive. She is recipient of the King of Norway’s Order of Merit and she was honored to be appointed to the U.S. President’s Council of Advisors on Science and Technology. She is an elected Fellow of the American Association for the Advancement of Science and elected member of the Council on Foreign Relations.